Literature DB >> 20826454

Pro-cathepsin D interacts with the extracellular domain of the beta chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth.

Mélanie Beaujouin1, Christine Prébois, Danielle Derocq, Valérie Laurent-Matha, Olivier Masson, Sophie Pattingre, Peter Coopman, Nadir Bettache, Jami Grossfield, Robert E Hollingsworth, Hongyu Zhang, Zemin Yao, Bradley T Hyman, Peter van der Geer, Gary K Smith, Emmanuelle Liaudet-Coopman.   

Abstract

Interactions between cancer cells and fibroblasts are crucial in cancer progression. We have previously shown that the aspartic protease cathepsin D (cath-D), a marker of poor prognosis in breast cancer that is overexpressed and highly secreted by breast cancer cells, triggers mouse embryonic fibroblast outgrowth via a paracrine loop. Here, we show the requirement of secreted cath-D for human mammary fibroblast outgrowth using a three-dimensional co-culture assay with breast cancer cells that do or do not secrete pro-cath-D. Interestingly, proteolytically-inactive pro-cath-D remains mitogenic, indicating a mechanism involving protein-protein interaction. We identify the low-density lipoprotein (LDL) receptor-related protein-1, LRP1, as a novel binding partner for pro-cath-D in fibroblasts. Pro-cath-D binds to residues 349-394 of the β chain of LRP1, and is the first ligand of the extracellular domain of LRP1β to be identified. We show that pro-cath-D interacts with LRP1β in cellulo. Interaction occurs at the cell surface, and overexpressed LRP1β directs pro-cath-D to the lipid rafts. Our results reveal that the ability of secreted pro-cath-D to promote human mammary fibroblast outgrowth depends on LRP1 expression, suggesting that pro-cath-D-LRP1β interaction plays a functional role in the outgrowth of fibroblasts. Overall, our findings strongly suggest that pro-cath-D secreted by epithelial cancer cells promotes fibroblast outgrowth in a paracrine LRP1-dependent manner in the breast tumor microenvironment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20826454      PMCID: PMC2964349          DOI: 10.1242/jcs.070938

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  56 in total

1.  Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain.

Authors:  Petra May; Y Krishna Reddy; Joachim Herz
Journal:  J Biol Chem       Date:  2002-03-20       Impact factor: 5.157

Review 2.  LRP: a multifunctional scavenger and signaling receptor.

Authors:  J Herz; D K Strickland
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 3.  The microenvironment of the tumour-host interface.

Authors:  L A Liotta; E C Kohn
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

4.  Candidate genes for the hypoxic tumor phenotype.

Authors:  A C Koong; N C Denko; K M Hudson; C Schindler; L Swiersz; C Koch; S Evans; H Ibrahim; Q T Le; D J Terris; A J Giaccia
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

5.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

Authors:  B Elenbaas; L Spirio; F Koerner; M D Fleming; D B Zimonjic; J L Donaher; N C Popescu; W C Hahn; R A Weinberg
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

6.  A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells.

Authors:  M Glondu; P Coopman; V Laurent-Matha; M Garcia; H Rochefort; E Liaudet-Coopman
Journal:  Oncogene       Date:  2001-10-18       Impact factor: 9.867

7.  Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low Density lipoprotein receptor-related protein in caveolae.

Authors:  Philippe Boucher; Pingsheng Liu; Michael Gotthardt; Thomas Hiesberger; Richard G W Anderson; Joachim Herz
Journal:  J Biol Chem       Date:  2002-02-19       Impact factor: 5.157

8.  Identification of the human Mnk2 gene (MKNK2) through protein interaction with estrogen receptor beta.

Authors:  K Slentz-Kesler; J T Moore; M Lombard; J Zhang; R Hollingsworth; M P Weiner
Journal:  Genomics       Date:  2000-10-01       Impact factor: 5.736

9.  Fibroblasts capture cathepsin D secreted by breast cancer cells: possible role in the regulation of the invasive process.

Authors:  N Heylen; L-M Vincent; V Devos; V Dubois; C Remacle; A Trouet
Journal:  Int J Oncol       Date:  2002-04       Impact factor: 5.650

10.  Procathepsin D interacts with prosaposin in cancer cells but its internalization is not mediated by LDL receptor-related protein.

Authors:  Valérie Laurent-Matha; Annick Lucas; Silke Huttler; Konrad Sandhoff; Marcel Garcia; Henri Rochefort
Journal:  Exp Cell Res       Date:  2002-07-15       Impact factor: 3.905

View more
  25 in total

1.  Quantitative Proteome Analysis of Mouse Liver Lysosomes Provides Evidence for Mannose 6-phosphate-independent Targeting Mechanisms of Acid Hydrolases in Mucolipidosis II.

Authors:  Sandra Markmann; Svenja Krambeck; Christopher J Hughes; Mina Mirzaian; Johannes M F G Aerts; Paul Saftig; Michaela Schweizer; Johannes P C Vissers; Thomas Braulke; Markus Damme
Journal:  Mol Cell Proteomics       Date:  2017-01-06       Impact factor: 5.911

2.  Hepatic deficiency of low density lipoprotein receptor-related protein-1 reduces high density lipoprotein secretion and plasma levels in mice.

Authors:  Joshua E Basford; Lauren Wancata; Susanna M Hofmann; R A Gangani D Silva; W Sean Davidson; Philip N Howles; David Y Hui
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

3.  Cathepsin D is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis.

Authors:  D Derocq; C Prébois; M Beaujouin; V Laurent-Matha; S Pattingre; G K Smith; E Liaudet-Coopman
Journal:  Oncogene       Date:  2011-11-14       Impact factor: 9.867

4.  LRP-1--CD44, a new cell surface complex regulating tumor cell adhesion.

Authors:  Gwenn Perrot; Benoit Langlois; Jérôme Devy; Albin Jeanne; Laurie Verzeaux; Sébastien Almagro; Hervé Sartelet; Cathy Hachet; Christophe Schneider; Emilie Sick; Marion David; Michel Khrestchatisky; Hervé Emonard; Laurent Martiny; Stéphane Dedieu
Journal:  Mol Cell Biol       Date:  2012-06-18       Impact factor: 4.272

5.  Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1.

Authors:  Dan Zhao; Shereen Amria; Azim Hossain; Kumaran Sundaram; Peter Komlosi; Mitzi Nagarkatti; Azizul Haque
Journal:  Cell Immunol       Date:  2011-08-18       Impact factor: 4.868

6.  Human herpesvirus 8 interleukin-6 contributes to primary effusion lymphoma cell viability via suppression of proapoptotic cathepsin D, a cointeraction partner of vitamin K epoxide reductase complex subunit 1 variant 2.

Authors:  Daming Chen; Yang Gao; John Nicholas
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

7.  New cathepsin D inhibitor library utilizing hydroxyethyl isosteres with cyclic tertiary amines.

Authors:  Rose M McConnell; Kalyani Inapudi; Naveen Kadasala; Karthika Yarlagadda; Priya Velusamy; Matthew S McConnell; Adam Green; Carol Trana; Kelley Sayyar; James S McConnell
Journal:  Med Chem       Date:  2012-11       Impact factor: 2.745

8.  Procathepsin E is highly abundant but minimally active in pancreatic ductal adenocarcinoma tumors.

Authors:  Anthony J O'Donoghue; Sam L Ivry; Chaity Chaudhury; Daniel R Hostetter; Douglas Hanahan; Charles S Craik
Journal:  Biol Chem       Date:  2016-09-01       Impact factor: 3.915

9.  A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment.

Authors:  Lindsay B Alcaraz; Aude Mallavialle; Timothée David; Danielle Derocq; Frédéric Delolme; Cindy Dieryckx; Caroline Mollevi; Florence Boissière-Michot; Joëlle Simony-Lafontaine; Stanislas Du Manoir; Pitter F Huesgen; Christopher M Overall; Sophie Tartare-Deckert; William Jacot; Thierry Chardès; Séverine Guiu; Pascal Roger; Thomas Reinheckel; Catherine Moali; Emmanuelle Liaudet-Coopman
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.556

10.  c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis.

Authors:  Lucia Knopfová; Petr Beneš; Lucie Pekarčíková; Markéta Hermanová; Michal Masařík; Zuzana Pernicová; Karel Souček; Jan Smarda
Journal:  Mol Cancer       Date:  2012-03-23       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.